Cargando…

Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the developed world. Simple hepatic steatosis is mild, but the coexistence of steatohepatitis (NASH) and fibrosis increases the risk of hepatocellular carcinoma. Proper dietary and pharmacological treatment is essen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeznach-Steinhagen, Anna, Ostrowska, Joanna, Czerwonogrodzka-Senczyna, Aneta, Boniecka, Iwona, Shahnazaryan, Urszula, Kuryłowicz, Alina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571590/ https://www.ncbi.nlm.nih.gov/pubmed/31137547 http://dx.doi.org/10.3390/medicina55050166

Ejemplares similares

Stress as a factor contributing to obesity in patients qualified for bariatric surgery – studies in a selected group of patients (a pilot study)
por: Boniecka, Iwona, et al.
Publicado: (2017)

Higher Muscle Mass and Higher Serum Prealbumin Levels Are Associated with Better Survival in Hemodialysis Patients during a Five-Year Observation Period
por: Jeznach-Steinhagen, Anna, et al.
Publicado: (2023)

Nutritional Status, Selected Nutrients Intake, and Metabolic Disorders in Bariatric Surgery Patients
por: Boniecka, Iwona, et al.
Publicado: (2023)

The Impact of the COVID-19 Epidemic on the Mood and Diet of Patients Undergoing Bariatric Surgery
por: Boniecka, Iwona, et al.
Publicado: (2022)

Role of Obesogens in the Pathogenesis of Obesity
por: Shahnazaryan, Urszula, et al.
Publicado: (2019)

Nutritional Status, Selected Nutrients Intake and Their Relationship with the Concentration of Ghrelin and Adiponectin in Patients with Diabetic Nephropathy
por: Boniecka, Iwona, et al.
Publicado: (2021)

Diet and Nutritional Status of Polish Girls with Rett Syndrome—A Case-Control Study
por: Czerwonogrodzka-Senczyna, Aneta, et al.
Publicado: (2023)

Development of obesity from childhood to adolescents
por: Majcher, Anna, et al.
Publicado: (2021)

The Concentration of Omega-3 Fatty Acids in Human Milk Is Related to Their Habitual but Not Current Intake
por: Bzikowska-Jura, Agnieszka, et al.
Publicado: (2019)

The Efficacy of Pharmacological Treatment in Pediatric Nonalcoholic Fatty Liver Disease
por: Cho, Taeshik, et al.
Publicado: (2012)

Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease
por: Ristic-Medic, Danijela, et al.
Publicado: (2022)

Maternal Nutrition and Body Composition During Breastfeeding: Association with Human Milk Composition
por: Bzikowska-Jura, Agnieszka, et al.
Publicado: (2018)

Dietary recommendations for patients with nonalcoholic fatty liver disease
por: Kargulewicz, Angelika, et al.
Publicado: (2014)

Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease
por: Valenti, Luca, et al.
Publicado: (2013)

The association of dietary phytochemical index and nonalcoholic fatty liver disease
por: Ahmadi, Bijan, et al.
Publicado: (2023)

Dietary and Nutritional Interventions in Nonalcoholic Fatty Liver Disease in Pediatrics
por: Farías, Camila, et al.
Publicado: (2023)

Dietary Sodium and Nonalcoholic Fatty Liver Disease: A Systematic Review
por: da Silva Ferreira, Guilherme, et al.
Publicado: (2023)

Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology
por: Huang, Yuanshe, et al.
Publicado: (2022)

Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease
por: Arvind, Ashwini, et al.
Publicado: (2021)

Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV
por: de Almeida, Cristiane Fonseca, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease
por: Park, Grace, et al.
Publicado: (2021)

Pharmacological Effects and Molecular Protective Mechanisms of Astragalus Polysaccharides on Nonalcoholic Fatty Liver Disease
por: Zhang, Jing, et al.
Publicado: (2022)

Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials
por: An, Jihyun, et al.
Publicado: (2023)

Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology
por: Yu, Chenyang, et al.
Publicado: (2023)

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2010)

Nonalcoholic fatty liver disease: new treatments
por: Hardy, Timothy, et al.
Publicado: (2015)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease
por: Soleimani, Davood, et al.
Publicado: (2019)

The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosis
por: Ibrahim, Maryam K., et al.
Publicado: (2023)

The Role of Phytosterols in Nonalcoholic Fatty Liver Disease
por: Frasinariu, Otilia, et al.
Publicado: (2022)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
por: Boursier, Jerome, et al.
Publicado: (2015)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p0711a4j4f1qm4i1uc7vrr1ccj